{"id":322451,"date":"2025-10-22T00:14:12","date_gmt":"2025-10-22T00:14:12","guid":{"rendered":"https:\/\/www.europesays.com\/us\/322451\/"},"modified":"2025-10-22T00:14:12","modified_gmt":"2025-10-22T00:14:12","slug":"nucleus-debuts-first-open-weight-ai-models-for-ivf-and-genetic-optimization-2","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/us\/322451\/","title":{"rendered":"Nucleus Debuts First Open-Weight AI Models for IVF and Genetic Optimization"},"content":{"rendered":"<p><b>Classified in: <\/b><a href=\"https:\/\/www.lelezard.com\/en\/news\/science-technology\" target=\"_blank\" rel=\"noopener\">Science and technology<\/a><br \/><b>Subject: <\/b><a href=\"https:\/\/www.lelezard.com\/en\/subject1617-productservice.html\" target=\"_blank\" rel=\"noopener\">Product\/Service<\/a><\/p>\n<p>\nThe future of genetics must be open.<\/p>\n<p>\n<a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmynucleus.com%2F&amp;esheet=54342329&amp;newsitemid=20251021897353&amp;lan=en-US&amp;anchor=Nucleus+Genomics&amp;index=1&amp;md5=4b4a5a9b962aedd9835b865c6269485d\" shape=\"rect\" target=\"_blank\">Nucleus Genomics<\/a> today launched Nucleus Labs, its new AI genomics research arm, and released Origin, a family of nine genetic optimization models that outperform all previous accuracy benchmarks in predicting health and longevity from an embryo&#8217;s DNA.<\/p>\n<p>\nTrained and validated on millions of people, Origin forecasts risks for age-related conditions like heart disease and cancer across diverse ancestries. With just five embryos, couples can expect a greater than 50% risk reduction in common diseases like Alzheimer&#8217;s, diabetes, and cancers.<\/p>\n<p>\nFor couples pursuing IVF, Origin offers a new way to plan for long-term health from the very start of life. Families and clinicians can now make more informed decisions about their future child&#8217;s wellbeing. It represents a fundamental change in how IVF is conducted and sets a new standard of scientific rigor in reproductive genetics.<\/p>\n<p>\n<b>Why it matters<\/b><\/p>\n<p>\nIn a first for the genomics industry, Nucleus is making its science completely transparent by open-weighting its models. In doing so, patients, researchers, clinicians, and companies can now access and build upon the research.<\/p>\n<p>\n&#8220;Too much of genetic optimization has been shrouded in secrecy,&#8221; said Kian Sadeghi, Founder and CEO of Nucleus Genomics. &#8220;We reject that. There&#8217;s enormous potential to improve lifelong health starting before birth ? and IVF is where that potential becomes real. Progress in genomics will now be faster and safer because of the launch of Origin.&#8221;<\/p>\n<p>\n<b>Driving transparency: A new standard in reproductive genetics<\/b><\/p>\n<p>\nAlongside the launch, Nucleus introduced the Genetic Optimization Hub ? a place for industry leaders and top researchers to show their work and improve genetic prediction. Nucleus has open-weighted its Origin family of models on the hub, and has invited other researchers and companies to do the same.<\/p>\n<p>\nNucleus wants to encourage open collaboration across IVF and medical research to ensure responsible and rapid innovation.<\/p>\n<p>\n<b>A turning point for genomics<\/b><\/p>\n<p>\nThe release of Origin is the first in a planned series of open-weight models. Nucleus says future models will expand optimization power even further, while setting new norms for transparency, safeguards, and responsible use.<\/p>\n<p>\n&#8220;Technology doesn&#8217;t exist in a vacuum,&#8221; added Sadeghi. &#8220;Its impact depends on how responsibly it&#8217;s used. By open-weighting Origin, we want to set a global standard for safe, equitable, and effective genetic optimization.&#8221;<\/p>\n<p>\n<b>About Nucleus Genomics<\/b><\/p>\n<p>\nNucleus Genomics builds clinical-grade genetics software focused on generational health. Its flagship product, <b>Nucleus IVF+<\/b>, integrates deep genomic insight into IVF ? enabling families to plan for health and longevity from the earliest stage. <a rel=\"nofollow noopener\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fmynucleus.com%2F&amp;esheet=54342329&amp;newsitemid=20251021897353&amp;lan=en-US&amp;anchor=Learn+more&amp;index=2&amp;md5=299b3452913075de5df90196435d1cd4\" shape=\"rect\" target=\"_blank\">Learn more<\/a>.<\/p>\n<p>\nTo partner with Nucleus, please reach out to <a rel=\"nofollow noopener\" href=\"http:\/\/www.lelezard.com\/cdn-cgi\/l\/email-protection#7c0c1d0e0812190e0f14150c0f3c110512091f1019090f521f1311\" shape=\"rect\" target=\"_blank\">[email\u00a0protected]<\/a>.<\/p>\n<p><\/p>\n<tr>\n<td>\n            These press releases may also interest you<\/p>\n<tr class=\"r_21983106\">\n<td class=\"col_date\">\n\t\t\t\tat 20:00<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983106\">\n<td\/>\n<td>\n<p>Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&amp;C) and general insurance, announced it has been named a co-winner in the 2025 IDC FinTech Real Results Awards in the Insurance&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr class=\"r_21983084\">\n<td class=\"col_date\">\n\t\t\t\tat 18:40<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983084\">\n<td\/>\n<td>\n<p>Rocket Doctor AI Inc.  (&#8220;Rocket Doctor AI&#8221;) announces that we have engaged Fundamental Research Corp. (&#8220;FRC&#8221;), an independent small-cap research firm, for analyst coverage.    FRC is one of the largest independent research companies in the world with&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr class=\"r_21983081\">\n<td class=\"col_date\">\n\t\t\t\tat 18:26<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983081\">\n<td\/>\n<td>\n<p>Banking Labs Inc., an AI-powered financial intelligence firm, is proud to announce that it has been named the winner of the Global AI Innovation Award 2025 in the &#8220;People &amp; Organization&#8221; category for Outstanding Contribution by an AI Leader to an&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr class=\"r_21983059\">\n<td class=\"col_date\">\n\t\t\t\tat 17:53<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983059\">\n<td\/>\n<td>\n<p>Videotron Ltd. (&#8220;Videotron&#8221;) today announced that it has issued a conditional notice of redemption for all of its outstanding 51\/8% Senior Notes due April 15, 2027 (the &#8220;Notes&#8221;), of which there is US$600 million aggregate principal amount outstanding&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr class=\"r_21983049\">\n<td class=\"col_date\">\n\t\t\t\tat 17:40<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983049\">\n<td\/>\n<td>\n<p>Bone Solutions Inc., a Colleyville-based orthobiologics company specializing in magnesium-based technologies, announced that the U.S. Food and Drug Administration (FDA) has granted pediatric clearance for its Mg OSTEOCRETE and Mg OSTEOINJECT&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr class=\"r_21983039\">\n<td class=\"col_date\">\n\t\t\t\tat 17:32<\/td>\n<td\/>\n\t\t<\/tr>\n<tr class=\"r_21983039\">\n<td\/>\n<td>\n<p>Digital Turbine, Inc. , a global mobile platform company,\u00a0announced it will host a conference call and webcast to discuss its fiscal 2026 second quarter financial results and operating progress on Tuesday, November 4th, at 4:30pm ET\/1:30pm PT. The&#8230;<\/p>\n<p><\/td>\n<\/tr>\n<tr>\n<td\/>\n<td\/>\n\t<\/tr>\n<p><\/td>\n<\/tr>\n<p>News published on 21 october 2025 at 10:05 and distributed by: <br \/> <a href=\"https:\/\/www.businesswire.com\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" src=\"https:\/\/www.europesays.com\/us\/wp-content\/uploads\/2025\/10\/businesswire.jpg\" border=\"0\"\/><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Classified in: Science and technologySubject: Product\/Service The future of genetics must be open. Nucleus Genomics today launched Nucleus&hellip;\n","protected":false},"author":3,"featured_media":322452,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[26],"tags":[64,81,10833,6213,746,82437,815,210,20738,7709,47656,161215,50,10426,159,944,161214,62,1458,161213,5331,20944,522,161216,145981,161217,67,132,68],"class_list":{"0":"post-322451","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-genetics","8":"tag-business","9":"tag-business-news","10":"tag-computer-news","11":"tag-current-events","12":"tag-environment","13":"tag-environmental-news","14":"tag-genetics","15":"tag-health","16":"tag-health-news","17":"tag-holidays","18":"tag-leisure-activities","19":"tag-leisure-activities-news","20":"tag-news","21":"tag-press-release","22":"tag-science","23":"tag-sciences","24":"tag-scientific-news","25":"tag-sports","26":"tag-sports-news","27":"tag-technological-news","28":"tag-tourism","29":"tag-tourism-news","30":"tag-transportation","31":"tag-transportation-news","32":"tag-travelling","33":"tag-travelling-news","34":"tag-united-states","35":"tag-unitedstates","36":"tag-us"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@us\/115414939161026532","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/322451","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/comments?post=322451"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/posts\/322451\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media\/322452"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/media?parent=322451"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/categories?post=322451"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/us\/wp-json\/wp\/v2\/tags?post=322451"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}